TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank40
3Y CAGR-11.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-11.2%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$14.96M-15.4%
2024$17.69M-40.7%
2023$29.84M+39.7%
2022$21.36M+50.2%
2021$14.22M-
2020$0.00-